Anogen Life Sciences, Inc. — Form D
Anogen Life Sciences, Inc. of St. Petersburg, FL, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-05. The offering totals $408K, of which $408K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-05
- Form: D
- Accession: 0001800417-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $408K
- Amount sold: $408K
- Investors: 12
- Date of first sale: 2021-01-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-388554
Issuer
- Name: Anogen Life Sciences, Inc.
- CIK: 0001800417
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 7901 4th Street N, Suite 300, St. Petersburg, FL, 33702
- Phone: 404-934-7258
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David B Adair | Director | St. Petersburg, FL |
| Steven B Bettis | Director | St. Petersburg, FL |
| Andreas B Reiff | Director | St. Petersburg, FL |
| Seth B Yakatan | Director | St. Petersburg, FL |
| Steven B Bettis | Executive Officer | St. Petersburg, FL |
More